To evaluate whether the TMZ resistance-promoting effect of SCD1 was through an Akt-dependent mechanism, we first examined cell viability of GBM cells under pcDNA-SCD1 transfection and EGF treatment. The gene discussed is EGF; the disease is glioblastoma.